: Lilly’s COVID-19 treatment receives emergency-use approval from FDA, stock jumps 3%

admin 4 years ago No Comments

This post was originally published on this site

Eli Lilly & Co.’s COVID-19 antibody treatment was approved for emergency use by the Food and Drug Administration on Monday, and Lilly shares jumped more than 3% in after-hours trading.

Prev Article Next Article

Trump Today: Trump pins market drop on oil-price fight, ‘fake news’ with advisers set to present coronavirus response options

admin March 9, 2020

TaxWatch: ‘I’m trying not to work people into a downward spiral’: Why some parents should brace themselves for a lower tax refund in 2022

admin January 20, 2022

Economic Report: British economy suffered record collapse in the second quarter

admin August 12, 2020

Bond Report: Treasury yields post biggest one-day declines in almost two weeks

admin November 27, 2023

MarketWatch Premium: There’s more money to be made in stocks than in ETFs today — here’s why

admin April 9, 2021

Washington Watch: ‘Big mistake’ for China to skip COP26 in-person climate summit, Biden says

admin November 2, 2021

About The Author

admin

in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

By signing up above you will receive the Daily Buzz Offers newsletter and 3rd party advertisements. Expect up to 5 messages per week from us. You can unsubscribe at any time at the bottom of any of our emails.

Related Posts

About The Author

admin